Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

NIH grant supports RetroVirox's work in HIV

March 13, 2015

GlaxoSmithKline describes second-generation HIV-1 maturation inhibitor

March 13, 2015

MazF-modified T cells are safe and persistant in aviremic HIV patients

March 11, 2015

Novel acylguanidine-based small molecule inhibits HIV-1 replication

March 10, 2015

Studies advance darunavir/cobicistat/emtricitabine/tenofovir alafenamide single tablet formulation

March 9, 2015

CTX conditioning maximizes SB-728-T engraftment

March 5, 2015

Envelope-specific monoclonal antibodies offer a novel approach for the treatment of HIV infection

March 3, 2015

Tenofovir alafenamide fumarate subject of several presentations at CROI

March 3, 2015

Phase II data lead to phase III initiation for HIV candidate BMS-663068

March 3, 2015

Initiation of clinical trial of TLR7 agonist GS-9620 in HIV-positive patients on ART

March 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...